Antibiofilm and antimicrobial efficacy of Dispersinb®-KSL-w peptide-based wound gel against chronic wound infection associated bacteria

Current Microbiology

Volumn 68, Issue 5, 2014, Pages 635-641

  Gawande, Purushottam V ^a   Leung, Kai P ^b   Madhyastha, Srinivasa ^a  

^a Kane Biotech Inc   (Canada)

^b US ARMY INSTITUTE OF SURGICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; DISPERSINB; GELLING AGENT; POLOXAMER; POLYPEPTIDE ANTIBIOTIC AGENT; SILVER SEPT; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANTIMICROBIAL ACTIVITY; ARTICLE; BIOFILM; CHRONIC WOUND; COAGULASE NEGATIVE STAPHYLOCOCCUS; DRUG EFFICACY; DRUG FORMULATION; GEL; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS EPIDERMIDIS; VANCOMYCIN RESISTANT ENTEROCOCCUS; WOUND INFECTION;

ACINETOBACTER BAUMANNII; BACTERIA (MICROORGANISMS); KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS; STAPHYLOCOCCUS EPIDERMIDIS;

ACINETOBACTER BAUMANNII; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL PROTEINS; BIOFILMS; COLONY COUNT, MICROBIAL; DRUG SYNERGISM; GELS; GLYCOSIDE HYDROLASES; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY;

EID: 84896391473     PISSN: 03438651     EISSN: 14320991     Source Type: Journal    
DOI: 10.1007/s00284-014-0519-6     Document Type: Article

References (31)

1. Gottrup F (2004) A specialized wound-healing center concept: importance of a multidisciplinary department structure and surgical treatment facilities in the treatment of chronic wounds. Am J Surg 187:38S-43S
2. Konturek PC, Brzozowski T, Kouturek SJ, Kwiecien S, Dembinski A, Hahn EG (2001) Influence of bacterial lipopolysaccharide on healing of chronic experimental ulcer in rat. Scand J Gastroenterol 36:1239-1247
3. Gjodsbol K, Christensen JJ, Karlsmark T, Jorgensen B, Klein BM, Krogfelt KA (2006) Multiple bacterial species reside in chronic wounds: a longitudinal study. Int Wound J 3:225-231
4. James GA, Swogger E, Wolcott R, Pulcini E, Secor P, Sestrich J, Costerton JW, Stewart PS (2008) Biofilms in chronic wounds. Wound Repair Regen 16:37-44
5. Singh VA, Barbul A (2008) Bacterial biofilms in wounds. Wound Repair Regen 16:1
6. Costerton JW (2004) A short history of the development of the biofilm concept. In: Ghannoum M, O'Toole GA (eds) Microbial biofilms. ASM Press, Washington, DC, pp 4-19
7. Wolcott RD, Rhoads DD (2008) A study of biofilm-based wound management in subjects with critical limb ischemia. J Wound Care 17:145-155
8. Hong SY, Oh JE, Kwon MY, Choi MJ, Lee JH, Lee BL, Moon HM, Lee KH (1998) Identification and characterization of novel antimicrobial decapeptides generated by combinatorial chemistry. Antimicrob Agents Chemother 42:2534-2541
9. Na DH, Faraj J, Capan Y, Leung KP, DeLuca PP (2007) Stability of antimicrobial decapeptide (KSL) and its analogues for delivery in the oral cavity. Pharm Res 24:1544-1550
10. Kaplan JB, Ragunath C, Ramasubbu N, Fine DH (2003) Detachment of Actinobacillus actinomycetemcomitans biofilm cells by an endogenous beta- hexosaminidase activity. J Bacteriol 185:4693-4698
11. Kaplan JB (2009) Therapeutic potential of biofilm-dispersing enzymes. Int J Artif Organs 32:545-554
12. Leung K-P, Abercrombie JJ, Campbell TM, Gilmore KD, Bell CA, Faraj JA, DeLuca PP (2009) Antimicrobial peptides for plaque control. Adv Dent Res 21:57-62
13. Dumortier G, Grossiord JL, Agnely F, Chaumeil JC (2006) A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res 23:2709-2728
14. Concannon SP, Crowe TD, Abercrombie JJ, Molina CM, Raj PA, Leung K-P (2003) Susceptibility of oral bacteria to an antimicrobial decapeptide. J Med Microbiol 52:1083-1093
15. Castellano JJ, Shafii SM, Ko F, Donate G, Wright TE, Mannari RJ, Payne WG, Smith DJ, Robson MC (2007) Comparative evaluation of silver-containing antimicrobial dressings and drugs. Int Wound J 4:114-122
16. Izano EA, Sadovskay I, Vinogradov E et al (2007) Poly-N-acetylglucosamine mediates biofilm formation and antibiotic resistance in Actinobacillus pleuropneumoniae. Microb Pathog 43:1-9
17. ®-Triclosan wound gel against chronic wound associated bacteria. Open Antimicrob Agents J 3:12-16
18. Donlan RM, Costerton JW (2002) Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15:167-193
19. Choi AHK, Slamti L, Avci FY, Pier GB, Maria-Litran T (2009) The pgaABCD locus of Acinetobacter baumannii encodes the production of poly-β-N- acetylglucosamine, which is critical for biofilm formation. J Bacteriol 191:5953-5963
20. Itoh Y, Wang X, Hinnebusch BJ, Preston JF, Rome T (2005) Depolymerization of β-1,6-N-acetyl-d-glucosamine disrupts the integrity of diverse bacterial biofilms. J Bacteriol 187:382-387
21. ® combination. J Antimicrob Chemother 64:88-93
22. Donelli G, Francolini I, Romoli D, Guaglianone A, Piozzi C, Ragunath C, Kaplan JB (2007) Synergistic activity of dispersin B and cefamandole nafate in inhibition of staphylococcal biofilm growth on polyurethanes. Antimicrob Agents Chemother 51:2733-2740
23. Izano EA, Wang H, Ragunath C, Kaplan JB (2007) Detachment and killing of Aggregatibacter actinomycetemcomitans biofilms by dispersin B and SDS. J Dent Res 86:618-622
24. Gotz F (2002) Staphylococcus and biofilms. Mol Microbiol 43:1367-1378
25. Loh JV, Percival SL, Woods EJ, Williams NJ, Cochrane CA (2009) Silver resistance in MRSA isolated from wound and nasal sources in humans and animals. Int Wound J 6:32-38
26. Whitchurch CB, Tolker-Nielsen T, Ragas PC, Mattick JS (2002) Extracellular DNA required for bacterial biofilm formation. Science 295:1487
27. Flemming HC, Neu TR, Wozniak DJ (2007) The EPS matrix: the house of biofilm cells. J Bacteriol 189:7945-7947
28. Marvasi M, Visscher PT, Casillas Martinez L (2010) Exopolymeric substance (EPS) from Bacillua subtilis: polymers and genes encoding their synthesis. FEMS Microbiol Lett 313:1-9
29. Yeaman MR, Yount NY (2003) Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev 55:27-55
30. Harrison JJ, Turner RJ, Joo DA, Stan MA, Chan CS, Allan ND, Vrionis HA, Olson ME, Ceri H (2008) Copper and quaternary ammonium cations exert synergistic bactericidal and antibiofilm activity against Pseudomonas aeruginosa. Antimicrob Agents Chemother 52:2870-2881
31. Semlali A, Leung K-P, Curt S, Rouabhia M (2011) Antimicrobial decapeptide KSL-W attenuates Candida albicans virulence by modulating its effects on toll-like receptor, human β-defensin, and cytokine expression by engineered human oral mucosa. Peptide 32:859-867